We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$193M
AUM Growth
+$10.9M
Cap. Flow
+$1.56M
Cap. Flow %
0.81%
Top 10 Hldgs %
21.73%
Holding
197
New
30
Increased
22
Reduced
69
Closed
26

Top Buys

Rank Stock Value
1
WAB icon
Wabtec
WAB
+$1.73M
2
AMGN icon
Amgen
AMGN
+$1.64M
3
ALK icon
Alaska Air
ALK
+$1.12M
4
BFAM icon
Bright Horizons
BFAM
+$1.07M
5
CTVA icon
Corteva
CTVA
+$1.05M

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$1.38M
2
SPGI icon
S&P Global
SPGI
+$1.25M
3
PPG icon
PPG Industries
PPG
+$1.06M
4
MS icon
Morgan Stanley
MS
+$1.04M
5
SYF icon
Synchrony
SYF
+$940K

Sector Composition

Rank Sector Weight
1 Industrials 20.99%
2 Healthcare 17.56%
3 Technology 15.32%
4 Consumer Staples 12.76%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
51
Procter & Gamble
PG
$341B
$1.32M 0.69%
9,819
-1,300
-12% -$176K
LRCX icon
52
Lam Research
LRCX
$339B
$1.3M 0.68%
20,050
+6,550
+49% +$413K
UNP icon
53
Union Pacific
UNP
$169B
$1.28M 0.66%
5,841
-64
-1% -$14.3K
XOM icon
54
ExxonMobil
XOM
$696B
$1.27M 0.66%
20,170
ELV icon
55
Elevance Health
ELV
$90.6B
$1.24M 0.64%
3,240
-1,200
-27% -$459K
PLD
56
DELISTED
PROLOGIS
PLD
$1.2M 0.62%
10,062
GIS icon
57
General Mills
GIS
$19.6B
$1.15M 0.59%
18,838
-7,650
-29% -$473K
CARR icon
58
Carrier Global
CARR
$45.8B
$1.14M 0.59%
23,525
-17,700
-43% -$791K
INDB icon
59
Independent Bank
INDB
$3.96B
$1.11M 0.57%
14,658
-50
-0.3% -$4.02K
VIRT icon
60
Virtu Financial
VIRT
$5.12B
$1.08M 0.56%
39,276
-11,100
-22% -$330K
SYF icon
61
Synchrony
SYF
$24.7B
$1.08M 0.56%
22,270
-20,630
-48% -$940K
BFAM icon
62
Bright Horizons
BFAM
$3.28B
$1.06M 0.55%
+7,175
New +$1.07M
PEP icon
63
PepsiCo
PEP
$185B
$1.05M 0.54%
7,110
FDX icon
64
FedEx
FDX
$73B
$1.05M 0.54%
3,525
+250
+8% +$74.2K
INTC icon
65
Intel
INTC
$513B
$1.01M 0.52%
18,026
+9,875
+121% +$580K
CAH icon
66
Cardinal Health
CAH
$54.1B
$1.01M 0.52%
+17,675
New +$1.03M
MDT icon
67
Medtronic
MDT
$120B
$1.01M 0.52%
8,119
CTVA icon
68
Corteva
CTVA
$55.6B
$1.01M 0.52%
+22,703
New +$1.05M
ALK icon
69
Alaska Air
ALK
$4.45B
$1M 0.52%
+16,575
New +$1.12M
SBUX icon
70
Starbucks
SBUX
$110B
$979K 0.51%
8,755
-4,953
-36% -$560K
AZN icon
71
AstraZeneca
AZN
$251B
$967K 0.5%
8,075
-2,600
-24% -$285K
PCAR icon
72
PACCAR
PCAR
$64.5B
$943K 0.49%
+15,848
New +$972K
REGN icon
73
Regeneron Pharmaceuticals
REGN
$79.7B
$927K 0.48%
1,660
-200
-11% -$101K
PXD
74
DELISTED
Pioneer Natural Resource Co.
PXD
$914K 0.47%
+5,625
New +$884K
QRVO icon
75
Qorvo
QRVO
$10.4B
$906K 0.47%
4,630

Similar funds

New England Research & Management's Q2 2021 Portfolio in Review

As of Q2 2021, New England Research & Management held 197 positions worth $193M, up 6% from $182M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q2 2021 filing shows 30 new, 22 increased, 69 reduced and 26 closed positions. Its largest new stake was Wabtec: 21,365 shares worth $1.76M. The largest sale was Salesforce, an estimated $1.38M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

  • New England Research & Management's largest Q2 2021 buy was Wabtec: 21,365 shares worth $1.76M.
  • New England Research & Management added most to Walt Disney in Q2 2021, an estimated $861K increase.
  • New England Research & Management's biggest Q2 2021 reduction was PPG Industries, cutting an estimated $1.06M.
  • New England Research & Management fully exited Salesforce in Q2 2021, selling an estimated $1.38M.
  • New England Research & Management's ten largest holdings make up 22% of its $193M portfolio in Q2 2021.
  • New England Research & Management opened 30 new positions and closed 26 in Q2 2021.
  • New England Research & Management's portfolio value rose 6% quarter-over-quarter to $193M.

Based on New England Research & Management's 13F filing for Q2 2021, filed 15 Jul 2021.